SANOFI AVENTIS US FDA Approval ANDA 089539

ANDA 089539

SANOFI AVENTIS US

FDA Drug Application

Application #089539

Application Sponsors

ANDA 089539SANOFI AVENTIS US

Marketing Status

Discontinued001

Application Products

001CAPSULE, EXTENDED RELEASE;ORAL75MG0SLO-BIDTHEOPHYLLINE

FDA Submissions

ORIG1AP1989-05-10
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1990-03-27
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1990-05-30
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1990-05-30
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1990-05-30
LABELING; LabelingSUPPL6AP1990-08-10
LABELING; LabelingSUPPL7AP1990-11-20
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1996-03-19
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1998-12-01

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL10Null0
SUPPL12Null0

CDER Filings

SANOFI AVENTIS US
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 89539
            [companyName] => SANOFI AVENTIS US
            [docInserts] => ["",""]
            [products] => [{"drugName":"SLO-BID","activeIngredients":"THEOPHYLLINE","strength":"75MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"SLO-BID","submission":"THEOPHYLLINE","actionType":"75MG","submissionClassification":"CAPSULE, EXTENDED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.